Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Lamotrigine on Cognitive Deficits Associated With Neurofibromatosis Type 1: a Phase II Randomized Controlled Multi-centre Trial (NF1-EXCEL)

NCT02256124 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT02256124
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02256124 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Lamotrigine on Cognitive Deficits Associated With Neurofibromatosis Type 1: a Phase II Randomized Controlled Multi-centre Trial (NF1-EXCEL)
Lead sponsor
Erasmus Medical Center
Phase
Phase 2/3
Overall status
Terminated
Start date
October 31, 2014
Completion date
April 30, 2020
Enrollment
41 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatosis type 1